Jayfal (Nutmeg)

<h3> Absolute Contraindications of Jayfal (Nutmeg) </h3> <h4> Pregnancy (Avoid use in pregnancy)</h4> <ul> <li>🤰 <li>Recommendation: Avoid therapeutic or concentrated nutmeg (oils, large culinary doses or supplements) during pregnancy; keep only small culinary amounts. If you are pregnant, consult your healthcare provider before using nutmeg medicinally. <li>Reasoning: Animal studies show dose-dependent reductions in fertility and effects on reproductive tissues; in vitro data suggest anti-progesterone-like activity, making high exposures theoretically risky for pregnancy. Human safety data for medicinal doses in pregnancy are lacking. <li>Scientific_Study_Title: Effect of oil of nutmeg on the fertility and induction of meiotic chromosome rearrangements in mice and their first generation <li>Scientific_Study_Authors: J Pecevski, D Savković, D Radivojević, L Vuksanović <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/7194525/ <li>Scientific_Study_Excerpt: <p>The mouse study reported dose-dependent effects of nutmeg oil on fertility when male mice received oral oil for eight weeks. The highest dose group showed the greatest reduction in fertility, and chromosomal translocations appeared in F1 males derived from certain lower dose groups. These controlled animal findings indicate that concentrated nutmeg oil can alter reproductive outcomes at higher exposures, supporting a precautionary stance in pregnancy where fetal safety is concerned and human safety data are limited.</p> </ul> <h4>Breastfeeding (Nursing mothers - avoid medicinal doses)</h4> <ul> <li>🍼 <li>Recommendation: Do not use concentrated nutmeg or nutmeg oil while breastfeeding; small culinary amounts as flavoring are generally acceptable, but avoid spoonfuls or supplements. <li>Reasoning: Nutmeg’s myristicin and related compounds can produce anticholinergic effects and in vitro data suggest interactions with progesterone pathways; anticholinergic activity can reduce prolactin-mediated lactation and there is limited safety data in infants. <li>Scientific_Study_Title: Nutmeg (LactMed review) <li>Scientific_Study_Authors: No individual author listed (LactMed/NIH compilation) <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/30000898/ <li>Scientific_Study_Excerpt: <p>The LactMed review notes that nutmeg and its oils are GRAS in food amounts but that higher doses (for example a spoonful) can cause anticholinergic intoxication. It highlights the lack of clinical safety data for nursing mothers and infants and cites in vitro evidence for anti-progesterone activity that could theoretically affect lactation. The review therefore advises avoiding nutmeg and mace at amounts higher than typical culinary use during breastfeeding.</p> </ul> <h4>Known severe psychiatric illness or psychosis (history of psychosis / severe mania)</h4> <ul> <li>🧠 <li>Recommendation: Avoid medicinal or high-dose nutmeg in people with psychotic spectrum disorders or a history of severe psychiatric instability; check with a psychiatrist before any herbal use. <li>Reasoning: Large doses can produce delirium, hallucinations, severe agitation and behavioral disturbances; an intoxication episode could worsen an underlying psychotic disorder or trigger dangerous agitation. <li>Scientific_Study_Title: Nutmeg Intoxication: A Case Report <li>Scientific_Study_Authors: Casale M, et al. <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/37915877/ <li>Scientific_Study_Excerpt: <p>Emergency department case reports document that ingestion of large amounts of nutmeg powder produced hyperactive delirium with anticholinergic features, severe agitation and the need for critical care observation in at least one recent case. Such clinical reports illustrate the real-world potential for nutmeg to precipitate or amplify psychiatric symptoms - hence strong caution where severe mental illness or vulnerability to psychosis exists.</p> </ul> <h4>Children and infants - unintentional ingestion (high risk for toxicity)</h4> <ul> <li>🧒 <li>Recommendation: Keep nutmeg and nutmeg products out of reach of children; do not give medicinal or large quantities to infants or children. Seek urgent medical care for suspected ingestion of large amounts. <li>Reasoning: Case reports describe severe seizures and status epilepticus following nutmeg ingestion in infants/young children, showing that small bodies are much more vulnerable to myristicin and related metabolites. <li>Scientific_Study_Title: Myristicin and phenytoin toxicity in an infant <li>Scientific_Study_Authors: (see PubMed record) - Aydin K, et al. (PubMed listing) <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/24903724/ <li>Scientific_Study_Excerpt: <p>An infant developed recurrent afebrile status epilepticus after nutmeg ingestion; subsequent management was complicated by phenytoin toxicity. The initial convulsions were temporally linked to myristicin exposure, and the report underscores that even household spices can cause severe neurologic toxicity in young children. This supports treating nutmeg ingestion in children as potentially serious and avoiding medicinal use in this age group.</p> </ul> <h3> Relative Contraindications of Jayfal (Nutmeg) </h3> <h4>Concomitant use with monoaminergic/serotonergic medications (SSRIs, SNRIs, MAOIs)</h4> <ul> <li>⚠️ <li>Recommendation: Avoid high-dose nutmeg (supplements or oils); if taking antidepressants or MAOIs, consult your prescriber before using nutmeg medicinally. <li>Reasoning: Myristicin and some nutmeg constituents have slight MAO-inhibitory and serotonergic activity in vitro and in animal models; combined serotonergic effects with medications theoretically increase risk of serotonin-related adverse effects, though direct clinical reports are limited. <li>Scientific_Study_Title: Pharmacological and Therapeutic Potential of Myristicin: A Literature Review <li>Scientific_Study_Authors: Multiple authors (review, MDPI Molecules 2021) <li>Scientific_Study_Link: https://www.mdpi.com/1420-3049/26/19/5914 <li>Scientific_Study_Excerpt: <p>The review summarizes that myristicin exhibits slight monoamine oxidase inhibitory activity and interacts with serotonergic receptors in preclinical work; these pharmacodynamic features can theoretically raise serotoninergic tone and interact with psychotropic drugs. While direct human interaction cases are sparse, the biochemical profile advises caution when combining concentrated nutmeg preparations with serotonergic or MAO-inhibiting medications.</p> </ul> <h4>Concurrent use of drugs metabolized by CYP1A2 (e.g., theophylline, tizanidine, clozapine)</h4> <ul> <li>💊 <li>Recommendation: If you take important CYP1A2-cleared medications, avoid consuming concentrated nutmeg extracts or oils; discuss with your clinician whether monitoring or dose adjustments are needed. <li>Reasoning: Myristicin causes mechanism-based inhibition of CYP1A2 in human liver systems; this can reduce clearance of sensitive drugs, increasing their plasma levels and toxicity risk. <li>Scientific_Study_Title: Identification and characterization of reactive metabolites in myristicin-mediated mechanism-based inhibition of CYP1A2 <li>Scientific_Study_Authors: Hsu et al. (2015) <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26091900/ <li>Scientific_Study_Excerpt: <p>In vitro human microsomal studies demonstrated that myristicin produced time-dependent, mechanism-based inhibition of CYP1A2 and generated reactive quinone/quinone-tautomer metabolites captured by glutathione. The findings show a plausible biochemical basis for significant herb-drug interactions when nutmeg constituents are present at sufficient concentrations to inhibit hepatic CYP1A2 activity.</p> </ul> <h4>Pre-existing liver disease or concurrent use of hepatotoxic drugs</h4> <ul> <li>🩺 <li>Recommendation: Use caution and consult a hepatologist or provider before using concentrated nutmeg products if you have liver disease or take hepatotoxic medications. <li>Reasoning: While some nutmeg constituents show hepatoprotective activity in models, preclinical studies also show formation of reactive metabolites that can bind biomolecules (RNA adducts), so net effects may vary with dose and context. <li>Scientific_Study_Title: RNA Adduction Resulting from the Metabolic Activation of Myristicin by P450 Enzymes and Sulfotransferases <li>Scientific_Study_Authors: Zhao et al. <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/38959404/ <li>Scientific_Study_Excerpt: <p>This study detected nucleoside adducts in RNA after myristicin exposure in hepatocytes and mouse liver, indicating bioactivation by cytochrome P450s and sulfotransferases to reactive metabolites capable of covalent binding. The data highlight a metabolic pathway that could contribute to toxicity under certain exposure conditions, arguing for caution in patients with compromised liver function or polypharmacy involving hepatically metabolized drugs.</p> </ul>